Archives     Advertise     Editorial Calendar     Subscribe     Contact Us    



Alexander Leads Bipartisan Support for Accelerated FDA Reviews


 

On Aug. 2, the U.S. Senate passed bipartisan legislation led by health committee Chairman Lamar Alexander (R-Tenn.) and Ranking Member Patty Murray (D-Wash.) intended to speed approval of safe drugs and medical devices.

Alexander said: "The Senate has sent to the president's desk legislation that will speed cures and treatments into patients' medicine cabinets. The first step was last year's passage of 21st Century Cures to spur medical research, and this is the next step -- ensuring patients see the benefits of those research advancements."

The legislation includes four different user fee agreements that must be reauthorized by Sept. 30. The bill is virtually identical to legislation overwhelmingly approved by the Senate's health committee on May 11. This legislation will reauthorize the authority for the Food and Drug Administration (FDA) to accept user fees - paid by manufacturers of drugs and medical devices - that account for $8 to $9 billion over 5 years and is over a quarter of all FDA funding. The reauthorizations are based on recommendations from industry and FDA after a public process.

Over the last year and a half, the HELP Committee that Alexander chairs has held 15 bipartisan briefings, including some with the House Energy and Commerce Committee, to hear from FDA and industry about the reauthorization. The HELP Committee held two bipartisan hearings, on March 21 and April 4, on the medical device and drug user fees. The committee held a markup on the bill on May 11, when two bipartisan amendments were adopted, and the committee overwhelmingly approved the bill -- voting 21 to 2.

The bill includes provisions from:

  • Sens. Isakson and Bennet to improve the medical device inspection process.
  • Sens. Hassan and Young to improve communication about abuse-deterrent opioid products.
  • Sens. Enzi and Franken to encourage medical device development for children, and make sure FDA has appropriate expertise to review devices for children.
  • Sens Roberts, Donnelly, and Burr to allow more appropriate classification of accessories used with medical devices.
  • Sens Collins, Franken, McCaskill, and Cotton to improve generic drug development and help lower prescription drug costs.
  • Sens. Hatch, Bennet, Burr, and Casey to improve access to clinical trials for all patients.
  • Sens. Bennet, Rubio, Van Hollen, and Gardner to increase the development of new drugs to treat pediatric cancers and other diseases.
 
Share:

Related Articles:


Recent Articles

Post-Flu Risks A Growing Concern For The Elderly

Infectious disease experts are warning that flu can lead to an increased risk of heart attack, stroke and disability in elderly patients for months after they have recovered from their illness.

Read More

Meharry & HCA Join Forces for Training Physicians

Meharry students to train in HCA system.

Read More

Hospital Groups File Lawsuit To Stop Significant Payment Cuts For 340B Hospitals

Today, the American Hospital Association (AHA), the Association of American Medical Colleges (AAMC) and America's Essential Hospitals filed a lawsuit against the U.S. Department of Health and Human Services (HHS) in the U.S. District Court for the District of Columbia to prevent significant Medicare payment cuts for hospitals that participate in the 340B Drug Pricing Program.

Read More

CMS proposes policies to lower the cost of prescription drugs and combat the opioid crisis

The proposed rule eliminates administrative hurdles to providing more affordable prescription drugs and will allow Medicare to combat opioid overprescribing and abuse.

Read More

Tax Reform & Healthcare

Medicare cuts and repeal of the individual mandate are two areas of tax reform directly impacting healthcare.

Read More

Senate HELP Committee Hearing on Gene Editing Technology

On Nov. 14, the Senate health committee held a hearing on the gene editing method CRISPR to learn more about the technology from expert witnesses, which included Dr. Matthew Porteus, associate professor of Pediatrics at Stanford University; Katrine Bosley, CEO and president of Editas Medicine; and Dr. Jeffrey Kahn, director of the Johns Hopkins Berman Institute of Bioethics at Johns Hopkins School of Public Health.

Read More

Nashville Health Care Council Hosts Panel Discussion on Pharma/Provider Collaborations in Health Care

On Nov. 13, the Nashville Health Care Council hosted a panel discussion on collaborations between the pharmaceutical and healthcare provider sectors and how those collaborations can drive change in healthcare.

Read More

Tennessee Health Care Hall of Fame Class of 2017

Six healthcare luminaries were recently inducted into the Tennessee Health Care Hall of Fame.

Read More

NMGMA 10 Minute Takeaway

Nashville Medical News recently had the opportunity to chat with new NMGMA president Joy Testa.

Read More

Tennessee Joins Medical Licensing Compact

A new Tennessee law will make it easier for area physicians to practice across state lines beginning in 2019 as part of the Interstate Medical Licensure Compact.

Read More

Email Print
 
 

 

 


Tags:
FDA, HELP Committee, Lamar Alexander, U.S. Senate
Powered by Bondware
News Publishing Software

The browser you are using is outdated!

You may not be getting all you can out of your browsing experience
and may be open to security risks!

Consider upgrading to the latest version of your browser or choose on below: